Is bilateral orchiectomy for metastatic prostate cancer treatment associated with high cardiovascular risk? - Abstract

Cardiovascular disease is one of the most common causes of death worldwide and the most usual in the western populations. Although it affects both sexes, it is more frequent in males in whom it shortens the average life expectancy. This difference has been attributed to the negative effects of testosterone; however, recent research showed that this hormone may have protective effects on the cardiovascular system. In confirmation to the above current evidence suggests that the low levels of testosterone could be associated with an increased CVD risk and with an augmentation of morbidity and mortality in males. In the present article, we present 2 cases of men with CVD and metastatic prostate cancer treated with bilateral orchiectomy who died of acute stroke during the perioperational period. The possible association of androgen deprivation with cardiovascular disease progression and the consequent risk of stroke are briefly discussed.

Written by:
Stamatiou K, Stamatopoulou E, Christopoulos G.   Are you the author?
General Hospital "TZANEIO", Piraeus, Greece.

Reference: Aging Dis. 2013 Oct 7;4(6):381-4.
doi: 10.14336/AD.2013.0400381


PubMed Abstract
PMID: 24307970

Go "Beyond the Abstract" - Read an article written by the authors for UroToday.com

UroToday.com Prostate Cancer Section